TechTeam's support services allow pharmaceutical companies to more
effectively execute eClinical trials
BOSTON, Mass., June 23 /PRNewswire-FirstCall/ -- TechTeam Global, Inc. (Nasdaq: TEAM), a worldwide provider of information technology (IT), enterprise support and business process outsourcing services, today announced the creation of a Global Pharmaceutical Center of Excellence.
The "Pharma" Center of Excellence will focus on high-quality delivery and continuous enhancement of TechTeam's eClinical Support Services and will also ensure that TechTeam's IT outsourcing services, such as service desk and infrastructure management, are aligned with the unique needs of the pharmaceutical industry. The Pharma Center of Excellence will serve as a clearinghouse of subject matter expertise and best practices, and includes more than 60 people. TechTeam currently supports more than 350 clinical trials, in 25 languages, across 13,000 sites worldwide.
"The pharmaceutical industry has unique and quickly evolving needs. With TechTeam's global support structure, industry focus and scalable model, we offer a flexible and agile approach to meet those needs. We provide customers with both a wide range of exceptional support services and the ability to implement them quickly and efficiently," said Joanna Gutkowski, who will lead TechTeam's Pharma Center of Excellence.
eClinical trials give the pharmaceutical industry more accurate and faster access to data, which can then be analyzed more quickly than possible with traditional methods. Ultimately, the use of an eClinical trial approach can shorten the time needed to conduct clinical research by months or even years.
TechTeam helps customers get the most value from eClinical technology by offering services such as multilingual help desk, user and application administration, site assessment, site connectivity, hardware provisioning and local study site training. Its service professionals are specially trained in pharma regulatory compliance, clinical trial process and industry standard eClinical applications for functions such as Electronic Data Capture (EDC), Remote Data Capture (RDC) and eDiary.
According to Gary J. Cotshott, President and Chief Executive Officer of TechTeam Global, pharmaceutical companies, clinical research organizations and industry software vendors will benefit from TechTeam's new Pharma Center of Excellence.
"We have provided support to customers in the pharmaceutical industry for nearly a decade. The decision to create a Pharma Center of Excellence reflects our commitment to the pharmaceutical industry and to meeting its growing needs. We want to ensure that all of the services available to our customers are designed, delivered and managed with careful consideration of the unique needs of this important industry," said Cotshott.
"In the future, we foresee the focus of the Center of Excellence broadening to cover the full life sciences industry. As always, we will continue to work closely with our customers as we set priorities and refine our capabilities," said Cotshott.
About TechTeam Global, Inc.
TechTeam Global, Inc. is a worldwide provider of information technology, enterprise support and business process outsourcing services to Fortune 1000 corporations, multinational companies, product providers, small and medium- sized companies, and government entities. TechTeam's ability to integrate computer services into a flexible, ITIL-based solution is a key element of its strategy. Partnerships with some of the world's "best-in-class" corporations provide TechTeam with unique expertise and experience in providing information technology support solutions. For information about TechTeam Global, Inc. and its services, call 800-522-4451 from the United States or visit our Web sites at http://www.techteam.com and http://www.techteam.eu. TechTeam's common stock is traded on the Nasdaq Global Market under the symbol "TEAM."
Safe Harbor Statement
The statements contained in this press release that are not purely historical, including statements regarding the Company's expectations, hopes, beliefs, intentions, or strategies regarding the future, are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Such factors include, but are not limited to, the ability of TechTeam to continue to further develop and implement its Pharma Center of Excellence and broaden its capabilities to include other parts of the life sciences industry. All forward-looking statements included in this press release are based on information available to the Company on the date hereof, and the Company assumes no obligation to update any such forward-looking statement. Prospective investors should also review all aspects of the Company's Reports on Forms 8-K, 10-Q, and 10-K filed with the United States Securities and Exchange Commission, including Management's Discussion and Analysis, and the risks described therein from time to time.
|SOURCE TechTeam Global, Inc.|
Copyright©2008 PR Newswire.
All rights reserved